Feb 23, 2007
Research and Markets has announced the addition of the Decision Resources, Inc. report: Repositioning ADME Studies: A Strategy to Reduce Drug Attrition to their offering.
The report describes the four categories of ADME: absorption, distribution, metabolism, and excretion; positioning in R&D process, benefits of moving ADME studies to earlier in the drug development process.
Company profiles: companies that provide ADME screening services and tools to the pharmaceutical industry, including Apredica Creative Research Solutions, and TechElan.
Outlook: how will companies implement ADME strategies in the future and what new tools will become available?
|
